Overactive bladder: recognition requires vigilance for symptoms

Cleve Clin J Med. 2007 May:74 Suppl 3:S21-9. doi: 10.3949/ccjm.74.suppl_3.s21.

Abstract

Overactive bladder (OAB) is a prevalent condition in both men and women that imposes significant burdens on the patient and his or her quality of life. Nevertheless, only a small percentage of patients with OAB receive diagnosis and treatment. The identification of OAB is well within the scope of the primary care provider, as it is symptom-based and does not generally require specialized testing. The treatment of OAB relies on behavioral modification and/or pharmacologic options, primarily antimuscarinic therapy. Better identification of OAB symptoms in the primary care setting should reduce the number of patients suffering from untreated OAB.

Publication types

  • Review

MeSH terms

  • Benzhydryl Compounds / therapeutic use
  • Cost of Illness
  • Cresols / therapeutic use
  • Female
  • Humans
  • Male
  • Mandelic Acids / therapeutic use
  • Mass Screening
  • Muscarinic Antagonists / therapeutic use
  • Phenylpropanolamine / therapeutic use
  • Prevalence
  • Quality of Life
  • Tolterodine Tartrate
  • Urinary Bladder, Overactive / diagnosis*
  • Urinary Bladder, Overactive / drug therapy
  • Urinary Bladder, Overactive / epidemiology
  • Urinary Bladder, Overactive / etiology

Substances

  • Benzhydryl Compounds
  • Cresols
  • Mandelic Acids
  • Muscarinic Antagonists
  • Phenylpropanolamine
  • Tolterodine Tartrate
  • oxybutynin